Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Pavla Perlíková is active.

Publication


Featured researches published by Pavla Perlíková.


Journal of Medicinal Chemistry | 2011

Synthesis and Significant Cytostatic Activity of 7-Hetaryl-7-deazaadenosines

Aurelie Bourderioux; Petr Nauš; Pavla Perlíková; Radek Pohl; Iva Pichová; Ivan Votruba; Petr Džubák; Petr Konečný; Marian Hajduch; Kirsten M. Stray; Ting Wang; Adrian S. Ray; Joy Y. Feng; Gabriel Birkus; Tomas Cihlar; Michal Hocek

A series of 7-aryl- and 7-hetaryl-7-deazaadenosines was prepared by the cross-coupling reactions of unprotected or protected 7-iodo-7-deazaadenosines with (het)arylboronic acids, stannanes, or zinc halides. Nucleosides bearing 5-membered heterocycles at the position 7 exerted potent in vitro antiproliferative effects against a broad panel of hematological and solid tumor cell lines. Cell cycle analysis indicated profound inhibition of RNA synthesis and induction of apoptosis in treated cells. Intracellular conversion to triphosphates has been detected with active compounds. The triphosphate metabolites showed only a weak inhibitory effect on human RNA polymerase II, suggesting potentially other mechanisms for the inhibition of RNA synthesis and quick onset of apoptosis. Initial in vivo evaluation demonstrated an effect of 7-(2-thienyl)-7-deazaadenine ribonucleoside on the survival rate in syngeneic P388D1 mouse leukemia model.


Journal of Medicinal Chemistry | 2014

Synthesis, Cytostatic, Antimicrobial, and Anti-HCV Activity of 6-Substituted 7-(Het)aryl-7-deazapurine Ribonucleosides

Petr Nauš; Olga Caletková; Petr Konečný; Petr Džubák; Kateřina Bogdanová; Milan Kolář; Jana Vrbkova; Lenka Poštová Slavětínská; Eva Tloušt’ová; Pavla Perlíková; Marian Hajduch; Michal Hocek

A series of 80 7-(het)aryl- and 7-ethynyl-7-deazapurine ribonucleosides bearing a methoxy, methylsulfanyl, methylamino, dimethylamino, methyl, or oxo group at position 6, or 2,6-disubstituted derivatives bearing a methyl or amino group at position 2, were prepared, and the biological activity of the compounds was studied and compared with that of the parent 7-(het)aryl-7-deazaadenosine series. Several of the compounds, in particular 6-substituted 7-deazapurine derivatives bearing a furyl or ethynyl group at position 7, were significantly cytotoxic at low nanomolar concentrations whereas most were much less potent or inactive. Promising activity was observed with some compounds against Mycobacterium bovis and also against hepatitis C virus in a replicon assay.


ChemBioChem | 2015

Polymerase Synthesis and Restriction Enzyme Cleavage of DNA Containing 7-Substituted 7-Deazaguanine Nucleobases

Michaela Mačková; Soňa Boháčová; Pavla Perlíková; Lenka Poštová Slavětínská; Michal Hocek

Previous studies of polymerase synthesis of base‐modified DNAs and their cleavage by restriction enzymes have mostly related only to 5‐substituted pyrimidine and 7‐substituted 7‐deazaadenine nucleotides. Here we report the synthesis of a series of 7‐substituted 7‐deazaguanine 2′‐deoxyribonucleoside 5′‐O‐triphosphates (dGRTPs), their use as substrates for polymerase synthesis of modified DNA and the influence of the modification on their cleavage by type II restriction endonucleases (REs). The dGRTPs were generally good substrates for polymerases but the PCR products could not be visualised on agarose gels by intercalator staining, due to fluorescence quenching. The presence of 7‐substituted 7‐deazaguanine residues in recognition sequences of REs in most cases completely blocked the cleavage.


ChemMedChem | 2013

Synthesis and cytostatic and antiviral activities of 2'-deoxy-2',2'-difluororibo- and 2'-deoxy-2'-fluororibonucleosides derived from 7-(Het)aryl-7-deazaadenines.

Pavla Perlíková; Ludovic Eberlin; Petra Ménová; Veronika Raindlová; Lenka Poštová Slavětínská; Eva Tloušťová; Gina Bahador; Yu-Jen Lee; Michal Hocek

A series of sugar‐modified derivatives of cytostatic 7‐heteroaryl‐7‐deazaadenosines (2′‐deoxy‐2′‐fluororibo‐ and 2′‐deoxy‐2′,2′‐difluororibonucleosides) bearing an aryl or heteroaryl group at position 7 was prepared and screened for biological activity. The difluororibonucleosides were prepared by non‐ stereoselective glycosidation of 6‐chloro‐7‐deazapurine with benzoyl‐protected 2‐deoxy‐2,2‐difluoro‐D‐erythro‐pentofuranosyl‐1‐mesylate, followed by amination and aqueous Suzuki cross‐couplings with (het)arylboronic acids. The fluororibo derivatives were prepared by aqueous palladium‐catalyzed cross‐coupling reactions of the corresponding 7‐iodo‐7‐deazaadenine 2′‐deoxy‐2′‐fluororibonucleoside 20 with (het)arylboronic acids. The key intermediate 20 was prepared by a six‐step sequence from the corresponding arabinonucleoside by selective protection of 3′‐ and 5′‐hydroxy groups with acid‐labile groups, followed by stereoselective SN2 fluorination and deprotection. Some of the title nucleosides and 7‐iodo‐7‐deazaadenine intermediates showed micromolar cytostatic or anti‐HCV activity. The most active were 7‐iodo and 7‐ethynyl derivatives. The corresponding 2′‐deoxy‐2′,2′‐difluororibonucleoside 5′‐O‐triphosphates were found to be good substrates for bacterial DNA polymerases, but are inhibitors of human polymerase α.


Medicinal Research Reviews | 2017

Pyrrolo[2,3‐d]pyrimidine (7‐deazapurine) as a privileged scaffold in design of antitumor and antiviral nucleosides

Pavla Perlíková; Michal Hocek

7‐Deazapurine (pyrrolo[2,3‐d]pyrimidine) nucleosides are important analogues of biogenic purine nucleosides with diverse biological activities. Replacement of the N7 atom with a carbon atom makes the five‐membered ring more electron rich and brings a possibility of attaching additional substituents at the C7 position. This often leads to derivatives with increased base‐pairing in DNA or RNA or better binding to enzymes. Several types of 7‐deazapurine nucleosides with potent cytostatic or cytotoxic effects have been identified. The most promising are 7‐hetaryl‐7‐deazaadenosines, which are activated in cancer cells by phosphorylation and get incorporated both to RNA (causing inhibition of proteosynthesis) and to DNA (causing DNA damage). Mechanism of action of other types of cytostatic nucleosides, 6‐hetaryl‐7‐deazapurine and thieno‐fused deazapurine ribonucleosides, is not yet known. Many 7‐deazaadenosine derivatives are potent inhibitors of adenosine kinases. Many types of sugar‐modified derivatives of 7‐deazapurine nucleosides are also strong antivirals. Most important are 2′‐C‐methylribo‐ or 2′‐C‐methyl‐2′‐fluororibonucleosides with anti‐HCV activities (several compounds underwent clinical trials). Some underexplored areas of potential interest are also outlined.


Molecular Cancer Therapeutics | 2016

7-(2-Thienyl)-7-Deazaadenosine (AB61), a New Potent Nucleoside Cytostatic with a Complex Mode of Action

Pavla Perlíková; Gabriela Rylova; Petr Nauš; Tomáš Elbert; Eva Tloušťová; Aurelie Bourderioux; Lenka Poštová Slavětínská; Kamil Motyka; Dalibor Doležal; Pawel Znojek; Alice Nová; Monika Harvanova; Petr Džubák; Michal Šiller; Jan Hlaváč; Marian Hajduch; Michal Hocek

7-(2-Thienyl)-7-deazaadenosine (AB61) showed nanomolar cytotoxic activities against various cancer cell lines but only mild (micromolar) activities against normal fibroblasts. The selectivity of AB61 was found to be due to inefficient phosphorylation of AB61 in normal fibroblasts. The phosphorylation of AB61 in the leukemic CCRF-CEM cell line proceeds well and it was shown that AB61 is incorporated into both DNA and RNA, preferentially as a ribonucleotide. It was further confirmed that a triphosphate of AB61 is a substrate for both RNA and DNA polymerases in enzymatic assays. Gene expression analysis suggests that AB61 affects DNA damage pathways and protein translation/folding machinery. Indeed, formation of large 53BP1 foci was observed in nuclei of AB61-treated U2OS-GFP-53BP1 cells indicating DNA damage. Random incorporation of AB61 into RNA blocked its translation in an in vitro assay and reduction of reporter protein expression was also observed in mice after 4-hour treatment with AB61. AB61 also significantly reduced tumor volume in mice bearing SK-OV-3, BT-549, and HT-29 xenografts. The results indicate that AB61 is a promising compound with unique mechanism of action and deserves further development as an anticancer agent. Mol Cancer Ther; 15(5); 922–37. ©2016 AACR.


Angewandte Chemie | 2016

2‐Substituted dATP Derivatives as Building Blocks for Polymerase‐Catalyzed Synthesis of DNA Modified in the Minor Groove

Ján Matyašovský; Pavla Perlíková; Vincent Malnuit; Radek Pohl; Michal Hocek

Abstract 2′‐Deoxyadenosine triphosphate (dATP) derivatives bearing diverse substituents (Cl, NH2, CH3, vinyl, ethynyl, and phenyl) at position 2 were prepared and tested as substrates for DNA polymerases. The 2‐phenyl‐dATP was not a substrate for DNA polymerases, but the dATPs bearing smaller substituents were good substrates in primer‐extension experiments, producing DNA substituted in the minor groove. The vinyl‐modified DNA was applied in thiol–ene addition and the ethynyl‐modified DNA was applied in a CuAAC click reaction to form DNA labelled with fluorescent dyes in the minor groove


MedChemComm | 2013

6-Alkyl-, 6-aryl- or 6-hetaryl-7-deazapurine ribonucleosides as inhibitors of human or MTB adenosine kinase and potential antimycobacterial agents

Pavla Perlíková; Petr Konečný; Petr Nauš; Jan Snášel; Ivan Votruba; Petr Džubák; Iva Pichová; Marian Hajduch; Michal Hocek

Title 6-alkyl-, 6-aryl- and 6-hetaryl-7-deazapurine ribonucleosides previously known as nanomolar cytostatics were found to be potent inhibitors of either human or mycobacterial (MTB) adenosine kinase (ADK). Several new derivatives bearing bulky substituents at position 6 were non-cytotoxic but selectively inhibited MTB ADK. However, most of the nucleosides (ADK inhibitors) as well as their octadecylphosphate prodrugs were inactive in the whole cell assay of inhibition of Mycobacterium bovis growth. 6-Methyl-7-deazapurine ribonucleoside was found to be a potent antimycobacterial agent.


Nucleic Acids Research | 2016

Influence of major-groove chemical modifications of DNA on transcription by bacterial RNA polymerases

Veronika Raindlová; Martina Janoušková; Michaela Slavíčková; Pavla Perlíková; Soňa Boháčová; Nemanja Milisavljevič; Hana Šanderová; Martin Benda; Ivan Barvík; Libor Krásný; Michal Hocek

DNA templates containing a set of base modifications in the major groove (5-substituted pyrimidines or 7-substituted 7-deazapurines bearing H, methyl, vinyl, ethynyl or phenyl groups) were prepared by PCR using the corresponding base-modified 2′-deoxyribonucleoside triphosphates (dNTPs). The modified templates were used in an in vitro transcription assay using RNA polymerase from Bacillus subtilis and Escherichia coli. Some modified nucleobases bearing smaller modifications (H, Me in 7-deazapurines) were perfectly tolerated by both enzymes, whereas bulky modifications (Ph at any nucleobase) and, surprisingly, uracil blocked transcription. Some middle-sized modifications (vinyl or ethynyl) were partly tolerated mostly by the E. coli enzyme. In all cases where the transcription proceeded, full length RNA product with correct sequence was obtained indicating that the modifications of the template are not mutagenic and the inhibition is probably at the stage of initiation. The results are promising for the development of bioorthogonal reactions for artificial chemical switching of the transcription.


ChemMedChem | 2014

Bis-pyrene-modified unlocked nucleic acids: synthesis, hybridization studies, and fluorescent properties.

Pavla Perlíková; Maria Ejlersen; Niels Langkjær; Jesper Wengel

Efficient synthesis of a building block for the incorporation of a bis‐pyrene‐modified unlocked nucleic acid (UNA) into oligonucleotides (DNA*) was developed. The presence of bis‐pyrene‐modified UNA within a duplex leads to duplex destabilization that is more profound in DNA*/RNA and less distinct in DNA*/DNA duplexes. Nevertheless, the destabilization effect of bis‐pyrene‐modified UNA is weaker than that of unmodified UNA. Some oligonucleotides with bis‐pyrene‐modified UNA incorporations displayed superior mismatch discrimination capabilities. UV/Vis absorption and molecular modeling studies indicate that the pyrene groups of bis‐pyrene‐modified UNA are located in the major groove of a duplex. Oligonucleotides containing two bis‐pyrene‐modified UNA monomers showed low pyrene monomer emission in bulge‐containing duplexes, high pyrene monomer emission in fully matched duplexes, and 5‐(pyrenyl)uracil:pyrene exciplex emission in the single‐stranded form. Such fluorescent properties enable the application of bis‐pyrene‐modified UNA in the development of fluorescence probes for DNA/RNA detection and for detection of deletions at specific positions.

Collaboration


Dive into the Pavla Perlíková's collaboration.

Top Co-Authors

Avatar

Michal Hocek

Charles University in Prague

View shared research outputs
Top Co-Authors

Avatar

Petr Nauš

Academy of Sciences of the Czech Republic

View shared research outputs
Top Co-Authors

Avatar

Lenka Poštová Slavětínská

Academy of Sciences of the Czech Republic

View shared research outputs
Top Co-Authors

Avatar

Radek Pohl

Academy of Sciences of the Czech Republic

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Eva Tloušťová

Academy of Sciences of the Czech Republic

View shared research outputs
Top Co-Authors

Avatar

Ivan Votruba

Academy of Sciences of the Czech Republic

View shared research outputs
Top Co-Authors

Avatar

Gabriel Birkus

Academy of Sciences of the Czech Republic

View shared research outputs
Top Co-Authors

Avatar

Jesper Wengel

University of Southern Denmark

View shared research outputs
Top Co-Authors

Avatar

Eva Tloušt’ová

Academy of Sciences of the Czech Republic

View shared research outputs
Researchain Logo
Decentralizing Knowledge